Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Naltrexone in Borderline Personality Disorder

This study has been terminated.
(Difficulties in recruiting enough subjects)
Sponsor:
Information provided by:
Central Institute of Mental Health, Mannheim
ClinicalTrials.gov Identifier:
NCT00124839
First received: July 27, 2005
Last updated: April 14, 2008
Last verified: April 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2008
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)